389.22
price up icon1.02%   3.93
after-market After Hours: 386.01 -3.21 -0.82%
loading

Elevance Health Inc Stock (ELV) Forecast

The Elevance Health Inc (ELV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $500.48, representing a +28.59% increase from the current price of $389.22. The highest analyst price target is $518.80, and the lowest is $482.17.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELV Price Target
Average 497.37 (+27.79% Upside)
loading

Is Elevance Health Inc (ELV) A Buy Now?

Oscillators
Name Value Action
RSI(14) 54.06 Neutral
STOCH(9,6) 69.92 Neutral
STOCHRSI(14) 76.15 Neutral
MACD(12,26) -0.1429 Buy
ADX(14) 29.60 Sell
William %R -27.24 Neutral
CCI(14) 69.34 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
386.35
Buy
385.22
Buy
MA20
377.98
Buy
383.42
Buy
MA50
390.91
Sell
397.60
Sell
MA100
443.75
Sell
428.27
Sell
MA200
486.76
Sell
455.77
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, ELV could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ELV, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 54.06 indicates that ELV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 69.92 indicates that ELV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 76.15 indicates that ELV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 29.6 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.34 indicates that ELV is still overbought but not to an extreme extent.

Long-term ELV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Elevance Health Inc financial reports and earnings history, Elevance Health Inc (ELV) stock could reach $611.42 by 2030, $819.95 by 2040 and $1,049.29 by 2050. See the projected annual prices until 2050 of the Elevance Health Inc stock below:

  • Elevance Health Inc (ELV) is expected to reach an average price of $716.87 in 2035, with a high prediction of $743.78 and a low estimate of $685.75. This indicates an $84.18% rise from the last recorded price of $389.22.
  • Elevance Health Inc (ELV) stock is projected to chart a bullish course in 2040, with an average price target of $782.89, representing an $101.14% surge from its current level. The forecast ranges from a conservative $766.98 to a sky-high $819.95.
  • Our analysts predict Elevance Health Inc (ELV) to jump 144.01% by 2045, soaring from $928.09 to an average price of $949.73, potentially reaching $952.32. While $928.09 is the low estimate, the potential upside is significant.
  • Elevance Health Inc (ELV) stock is expected to climb by 2050, reaching an average of $1,018.63, a $161.71% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,049.29 and $1,010.80, respectively, highlighting the market's uncertainty.

Elevance Health Inc Stock (ELV) Year by Year Forecast

Elevance Health Inc Stock (ELV) Price Forecast for 2025

Elevance Health Inc Stock (ELV) is expected to reach an average price of $499.85 in 2025, with a high prediction of $545.31 and a low estimate of $454.39. This indicates an +28.42% rise from the last recorded price of $389.22.
Month Average Low High Change from today's price
February, 2025 $498.55 $482.17 $518.80 +28.09%
March, 2025 $492.72 $485.63 $540.35 +26.59%
April, 2025 $488.03 $487.26 $519.22 +25.39%
May, 2025 $485.47 $471.13 $524.32 +24.73%
June, 2025 $481.12 $454.39 $495.86 +23.61%
July, 2025 $516.60 $477.07 $523.37 +32.73%
August, 2025 $485.05 $482.21 $519.11 +24.62%
September, 2025 $478.21 $476.49 $498.67 +22.86%
October, 2025 $493.04 $474.20 $525.39 +26.67%
November, 2025 $521.80 $480.40 $525.27 +34.06%
December, 2025 $509.82 $502.28 $532.20 +30.98%

Elevance Health Inc Stock (ELV) Price Forecast for 2026

The predicted value for Elevance Health Inc (ELV) in 2026 is set at an average of $562.06. Estimates vary from a peak of $631.74 to a trough of $492.37, indicating an +44.41% surge from the present price of $389.22.
Month Average Low High Change from today's price
January, 2026 $507.96 $492.37 $532.02 +30.51%
February, 2026 $549.56 $504.86 $550.30 +41.19%
March, 2026 $542.71 $535.66 $560.18 +39.44%
April, 2026 $551.11 $537.40 $564.91 +41.59%
May, 2026 $572.46 $538.10 $585.92 +47.08%
June, 2026 $540.82 $532.59 $580.55 +38.95%
July, 2026 $565.02 $540.84 $594.53 +45.17%
August, 2026 $562.02 $549.35 $581.11 +44.40%
September, 2026 $593.14 $521.93 $604.37 +52.39%
October, 2026 $573.71 $563.00 $631.74 +47.40%
November, 2026 $606.20 $556.66 $619.68 +55.75%
December, 2026 $558.39 $547.55 $626.73 +43.46%

Elevance Health Inc Stock (ELV) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Elevance Health Inc (ELV) is $544.36, with a high forecast of $591.94 and a low forecast of $496.78. This indicates an +39.86% increase from the last price of $389.22.
Month Average Low High Change from today's price
January, 2027 $583.15 $550.94 $591.94 +49.82%
February, 2027 $561.44 $553.56 $586.92 +44.25%
March, 2027 $540.41 $524.03 $566.43 +38.84%
April, 2027 $534.71 $527.62 $582.30 +37.38%
May, 2027 $542.04 $529.36 $561.26 +39.26%
June, 2027 $527.74 $513.40 $566.55 +35.59%
July, 2027 $523.51 $496.78 $538.16 +34.50%
August, 2027 $548.20 $519.49 $565.79 +40.85%
September, 2027 $527.72 $524.88 $561.69 +35.58%
October, 2027 $521.01 $519.25 $541.43 +33.86%
November, 2027 $527.29 $517.03 $568.27 +35.47%
December, 2027 $564.88 $523.38 $568.35 +45.13%

Elevance Health Inc Stock (ELV) Price Forecast for 2028

In 2028, Elevance Health Inc (ELV) is projected to reach an average price of $604.29, with a high projection of $672.85 and a low estimate of $535.73. This indicates an +55.26% rise from the last price of $389.22.
Month Average Low High Change from today's price
January, 2028 $554.86 $548.95 $575.40 +42.56%
February, 2028 $561.76 $545.51 $575.31 +44.33%
March, 2028 $593.04 $535.73 $593.78 +52.37%
April, 2028 $586.32 $579.27 $603.75 +50.64%
May, 2028 $594.87 $581.16 $608.63 +52.84%
June, 2028 $616.35 $581.89 $629.77 +58.35%
July, 2028 $581.44 $573.21 $621.17 +49.39%
August, 2028 $605.78 $581.48 $635.29 +55.64%
September, 2028 $602.91 $590.24 $621.97 +54.90%
October, 2028 $593.82 $562.88 $606.73 +52.57%
November, 2028 $614.88 $595.31 $672.85 +57.98%
December, 2028 $647.49 $597.86 $660.97 +66.36%

Elevance Health Inc Stock (ELV) Price Forecast for 2029

The 2029 price forecast for Elevance Health Inc Stock (ELV) is $603.63 on average, with a high prediction of $668.09 and a low estimate of $539.16. This represents an +55.09% increase from the previous price of $389.22.
Month Average Low High Change from today's price
January, 2029 $599.84 $589.00 $668.09 +54.11%
February, 2029 $624.72 $592.43 $633.51 +60.51%
March, 2029 $603.14 $595.20 $628.53 +54.96%
April, 2029 $588.65 $576.43 $608.16 +51.24%
May, 2029 $576.69 $565.88 $624.25 +48.17%
June, 2029 $584.15 $571.47 $603.31 +50.08%
July, 2029 $596.87 $565.07 $608.79 +53.35%
August, 2029 $565.89 $539.16 $602.62 +45.39%
September, 2029 $590.72 $561.91 $608.21 +51.77%
October, 2029 $570.38 $567.54 $604.26 +46.55%
November, 2029 $563.80 $562.01 $584.19 +44.85%
December, 2029 $570.21 $559.85 $611.16 +46.50%

Elevance Health Inc Stock (ELV) Price Forecast for 2030

Elevance Health Inc Stock (ELV) is expected to reach an average price of $640.16 in 2030, with a high forecast of $713.96 and a low forecast of $566.36. This signifies an +64.47% surge from the last price of $389.22.
Month Average Low High Change from today's price
January, 2030 $607.95 $566.36 $611.42 +56.20%
February, 2030 $598.05 $592.05 $618.59 +53.65%
March, 2030 $605.09 $588.74 $618.60 +55.46%
April, 2030 $625.46 $579.08 $627.87 +60.70%
May, 2030 $629.92 $616.90 $647.32 +61.84%
June, 2030 $649.72 $627.61 $652.36 +66.93%
July, 2030 $660.23 $624.92 $673.63 +69.63%
August, 2030 $622.05 $613.82 $661.78 +59.82%
September, 2030 $666.49 $622.12 $669.74 +71.24%
October, 2030 $643.80 $631.13 $676.06 +65.41%
November, 2030 $634.84 $603.84 $647.66 +63.11%
December, 2030 $691.23 $636.35 $713.96 +77.59%
healthcare_plans CI
$288.59
price up icon 1.62%
healthcare_plans CVS
$53.15
price up icon 1.01%
healthcare_plans HUM
$284.67
price up icon 0.72%
healthcare_plans CNC
$63.66
price up icon 2.27%
healthcare_plans MOH
$297.44
price up icon 3.92%
Cap:     |  Volume (24h):